AU2365795A - Multiple administrations of anti-tnf antibody - Google Patents

Multiple administrations of anti-tnf antibody

Info

Publication number
AU2365795A
AU2365795A AU23657/95A AU2365795A AU2365795A AU 2365795 A AU2365795 A AU 2365795A AU 23657/95 A AU23657/95 A AU 23657/95A AU 2365795 A AU2365795 A AU 2365795A AU 2365795 A AU2365795 A AU 2365795A
Authority
AU
Australia
Prior art keywords
multiple administrations
tnf antibody
tnf
antibody
administrations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23657/95A
Other languages
English (en)
Inventor
Marc Feldmann
Ravinder Nath Maini
James N. Woody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kennedy Trust for Rheumatology Research
Janssen Biotech Inc
Original Assignee
Kennedy Institute of Rheumotology
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kennedy Institute of Rheumotology, Centocor Inc filed Critical Kennedy Institute of Rheumotology
Publication of AU2365795A publication Critical patent/AU2365795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU23657/95A 1995-04-20 1995-04-20 Multiple administrations of anti-tnf antibody Abandoned AU2365795A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002218522A CA2218522A1 (fr) 1995-04-20 1995-04-20 Administrations multiples d'anticorps diriges contre le facteur necrosant des tumeurs (anticorps anti-tnf)
PCT/US1995/005155 WO1996033204A1 (fr) 1995-04-20 1995-04-20 Administrations multiples d'anticorps diriges contre le facteur necrosant des tumeurs (anticorps anti-tnf)

Publications (1)

Publication Number Publication Date
AU2365795A true AU2365795A (en) 1996-11-07

Family

ID=25679734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23657/95A Abandoned AU2365795A (en) 1995-04-20 1995-04-20 Multiple administrations of anti-tnf antibody

Country Status (4)

Country Link
EP (1) EP0871641A4 (fr)
AU (1) AU2365795A (fr)
CA (1) CA2218522A1 (fr)
WO (1) WO1996033204A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US7494652B1 (en) 1998-06-10 2009-02-24 Promega Corporation Treatment of sepsis
US6395273B1 (en) 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
TW201705980A (zh) 2004-04-09 2017-02-16 艾伯維生物技術有限責任公司 用於治療ＴＮＦα相關失調症之多重可變劑量療法
CN101500607B (zh) 2005-05-16 2013-11-27 阿布维生物技术有限公司 TNFα抑制剂治疗腐蚀性多关节炎的用途
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
GB201522394D0 (en) 2015-12-18 2016-02-03 Ucb Biopharma Sprl Antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10399036I1 (de) * 1989-08-07 2004-04-01 Peptide Technology Ltd Bindeligande für Tumornekrosisfaktor.

Also Published As

Publication number Publication date
EP0871641A4 (fr) 2001-09-26
WO1996033204A1 (fr) 1996-10-24
CA2218522A1 (fr) 1996-10-24
EP0871641A1 (fr) 1998-10-21

Similar Documents

Publication Publication Date Title
AU5869596A (en) Anti-gp130 monoclonal antibodies
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU3811495A (en) Antibodies
AU4735196A (en) L-plate
AU5893696A (en) Modification of polypeptides
AU5917796A (en) Streptavidin mutants
AU4992997A (en) Humanized anti-cd11a antibodies
AU5893796A (en) Modification of polypeptides
AUPN178995A0 (en) Antigen composition
AU6137996A (en) Antigen non-specific glycosylation inhibiting factor derivatives
AU2365795A (en) Multiple administrations of anti-tnf antibody
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5021796A (en) Recombinant human anti-lewis b antibodies
AU4396396A (en) Baby-bathing aid
AU7520396A (en) Abl-interactor protein
AU5284296A (en) Immune-evading proteins
AU7113696A (en) Detection and quantitation of 8-oh-adenine using monoclonal antibodies
AU2993095A (en) Cyclone
AU5100696A (en) Specific hiv-1 group o antigens
AU7537596A (en) Improved nogging for building purposes
AU6153396A (en) E6ap-binding proteins
ZA968873B (en) Isomerisation of equillin
AU6663896A (en) Broad specificity antibodies
AU4400396A (en) Anti-tpo monoclonal antibody
AU4778996A (en) Starting aid